Medindia » Medication Manual » Febuxostat

Febuxostat

Updated on : November - 2012
Latest prescription information about Febuxostat. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
Email Email print Print Save this page Save Syndicate Syndicate
Generic Name : Febuxostat
Pronunciation : feb ux' oh stat
Therapeutic Classification : Anti- Gout Medications
ICD Code : Y54.8
Trade Name(s): 
India- Goustat, Febucip, Feboxa, Goustat (80 mg), Feburic, Fabulas, Feboxa (80 mg), Febucip (80 mg), Fegout.
International- Uloric.
Why it is prescribed (Indications) : 
This medication is a xanthine oxidase (XO) inhibitor, prescribed for gout and hyperuricemia (high level of uric acid in blood). It decreases the amount of uric acid in blood. 
When it is not to be taken (Contraindications): 
Contraindicated in patients treated with azathioprine, mercaptopurine or theophylline.

Pregnancy Category :

A B C D X
Category C : Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Dosage & When it is to be taken : 
PO- The recommended dose is 40 to 80mg, once daily.
How it should be taken : 
It comes as a tablet to take by mouth with or without food.
Warnings and Precautions : 
* Caution should be exercised in patients with history of liver, kidney diseases, chest pain, cancer, stroke, elderly, children, pregnancy, and breastfeeding.
* Caution should be exercised in patients who have undergone organ transplantation (kidney, liver, heart and lung).
* If condition worsens, stop the medication immediately.
Side Effects : 
Most Common- Swelling in the face, lips, tongue or throat regions, sweating, general illness and loss of appetite.
Skin- Allergic reactions.
Respiratory - Difficulty in breathing.
Heart- Chest pain and heaviness in the chest region.
Gastrointestinal - Nausea and stomach pain.
Central Nervous System- Headache and confusion.
Eye- Vision problems.
Genitourinary- Dark colored urine.
Less Common- Anemia, pain, swelling in the joint regions, stroke and inflammation of liver.
Liver- Liver failure and jaundice.
Other Precautions : 
* Patient may develop with severe blood clot events; if so contact your healthcare provider immediately.
Storage Conditions : 
Store it at room temperature.
♦ Safety Labeling Changes Approved By FDA

Related News

Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment

A new drug called febuxostat has been found to reduce plasma levels of uric acid more effectively in Gout than the currently used drug allopurinol. If the results of the clinical trial are ...

Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

Browse the Drugs alphabetically

Reference  

  • Food and Drug Administration (FDA)
  • National Institutes of Health (NIH)
  • PubMed
  • CIMS
  • Indian Pharma Reference Guide 2012
Drugs Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z